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Since the discovery of swine influenza virus in 1931 (1),  of human influenza virus 
in 1933 (2), and subsequently of numerous strains of the latter which can be grouped 
into at least two distinct types (3), many investigators have studied the immunization 
of human beings and  animals  with such viruses in either  the active or inactivated 
state.  For a  time,  extracts of diseased  tissues,  usually mouse or ferret lungs, were 
used  (4--22);  but  following the  discovery that  the  extra-embryonic fluids of chick 
embryos infected with influenza virus are unusually rich in virus (23-26), such fluids 
have been used in most of the immunization studies.  Recently the trend has been 
to attempt immunization either by the administration  of allantoic fluids conta~ 
active virus to the respiratory tract (27-30), or by vaccination, usually subcutaneously 
in the case of man and intraperitoneally in the case of animals, with allantoic fluids 
containing either active or inactivated virus (28, 31-39).  In addition, immune sera 
have been used with varying degrees of success (41)-44) and although the method can 
probably be developed satisfactorily for the  temporary protection of small  groups 
of individuals, it is unlikely that it can be used when large populations are involved; 
hence, it will not be considered further here.  The use of active virus is fraught with 
dangers and presents problems that are best appreciated and coped with by patho- 
logists,  hence procedures  involving the administration  of active virus  will also be 
eliminated from the present discussion. 
It is possible that the great variation that has been reported in the effectiveness of 
vaccination with inactive virus was due largely to three interrelated factors, namely, 
differences in the ratio of virus to extraneous protein in the vaccine, variation in the 
amount of virus administered, and differences  in the degree of destruction of antigenic- 
ity of virus during inactivation.  No exhaustive study of these factors has been re- 
ported although there are many suggestions in the literature as to the importance of 
each.  For example, Andrewes and Smith (45) in a study of the effect of foreign tissue 
extracts on the efficacy of influenza virus vaccines concluded that "the relative poor- 
ness of vaccines made from heterologous species is probably accounted for by the fact 
that foreign tissue extracts interfere with the immunizing response," and  "that the 
antibody mechanism is so swamped by the large amount of foreign protein presented 
to it that it cannot deal so efficiently with the minute amount of virus it receives at 
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the same time."  There is a wide variation in the amount of virus present in tissue 
extracts and in infectious  extra-embryonic fluids,  and hence, in  vaccines prepared 
from such materials.  That the amount of virus in a vaccine is important was indi- 
cated in a  study on the quantitative relationship between the immunizing dose of 
epidemic influenza virus and the resultant immunity by Francis (13) who concluded 
that "a direct proportion exists between the concentration of epidemic influenza virus 
used for intraperitoneal immunization of mice and the degree of immunity to ~intra- 
nasal infection  which  develops."  The only comparative study in  which  vaccines 
were  used  that  contained  virus  more  concentrated  than  that  occurring  normally 
appears to be that of Hirst, Rickard, Whitman, and Horsfall (34).  These workers 
concluded  that "within certain limits the mean antibody response of human beings 
increased  as the amount of virus injected was increased.  When large amounts of 
influenza  A virus were given, the antibody response was of the same order of mag- 
nitude as that which occurred following actual infection by this virus."  The favorable 
results obtained with a vaccine concentrated by the red cell method may have been 
due to the fact that the virus content of this vaccine was somewhat greater than that 
which  obtains in extra-embryonic fluids  (39).  Experiments bearing on the loss of 
antigenicity on inactivation range from the early results with formalinized  prepara- 
tions (12, 15, 46) which indicated an essentially  complete loss of immunizing potency, 
to the results of Salk, Lavin, and Francis (47) who reported that a hundredfold loss in 
immunizing capacity occurs during inactivation and those of Eaton (17) which indi- 
cated a thirtyfold loss, to the results of Hirst and coworkers  (34) who reported that 
!'there was no significant  difference in the antibody response of human beings given 
active virus, formalin-inactivated virus, heat-inactivated virus, or virus inactivated 
by the drying process."  Although part of the variation in the results is probably due 
to differences in the kind of experiments conducted, it seems likely that differences in 
loss of antigenicity are responsible  for a considerable part of the variation, since in 
most of the work special attention was not paid to the determination and use of mini- 
mal amounts of inactivating agents. 
As a whole, the results just described, as well as those of other investigators 
(9, 20, 21, 38), provide ample evidence of the desirability of preparing concen- 
trated and purified vaccines, of determining the minimal amounts of treatment 
necessary for inactivation, and of establishing the optimum dosage for optimum 
antibody response and persistence of that response.  From a  practical stand- 
point, such vaccines should be purified sufficiently so that the virus represents 
the major antigenic component,  concentrated  sufficiently  so  that  the  virus 
content  is  several  times  that  present  in  infectious allantoic fluid,  and  in- 
activated  in  such  a  manner  that  appreciable  loss  of  immunizing  potency 
does not occur.  The present report records the preparation and properties of 
influenza virus vaccines concentrated and purified by means of differential cen- 
trifugation and inactivated by different procedures. 
Materials and Methods 
Virus Strcd~.--The PR8, Lee, and Weiss strains of influenza virus were all obtained from 
Dr. T. Francis, Jr., of the University of Michigan.  The recent passage history of the PR8 w.  M. STANLEY  195 
strain has been described (48).  When received in this laboratory the Lee strain had been 
isolated from ferret B75 following 8 passages in ferrets and then passed 137 times in mice and 
21 times in chick embryos.  The Weiss strain had been passed 3 times in ferrets, 23 times in 
mice, and 4 times in chick embryos when received.  Following 2 or 3 passages in chick embryos 
in this laboratory large pools of the three strains were prepared as described earlier (48). 
C/;ideen Red Cells, Red Cell Agglutination Titrations, Chi~k F.mbryo Titrations, Mouse Titra. 
tion:,  Nitrogen  Determinations,  ttigl*-Speed Centrifugogion, and  Sedimentation  Constants.-- 
These have been described earlier (48-53).  Unless otherwise noted all chicken red cell agglu- 
tination  (CCA) activities are given in standardized  units  (50). 
Ultraviolet Light Inaetivation.--Solutions  of virus to be inactivated were placed in open glass 
dishes in a hood under a Westinghouse Sterilamp in such a manner that the upper surfaces of 
inch layers of liquid were 4 inches from the tube of the lamp.  The solutions were stirred, 
usually two times, during the period of inactivation. 
Immunizing Potency.--The immunizing potency of the various vaccines was determined 
essentially according to the method recommended by Francis  (13),  and  Sulk, Lavin, and 
Francis (47).  In most of the experiments, four groups of twenty-two to twenty-four four- 
week-old mice from the colony of the Department of Animal and Plant Pathology of the Insti- 
tute were vaccinated intraperitoneaily on two occasions 7 to 9 days apart with 05 co. portions 
of dilutions of the vaccines in sterile 0.05 ~, sodium phosphate at pH 7 containing from 10  -4 
gin. to 10  -7 gin. of virus material per cc.  Seven to 9 days after the second intraperitoneal 
inoculation, four lots of five mice from each group were treated intranasally while under ether 
anesthesia with 0.05 cc. portions of four different concentrations of freshly harvested infectious 
allantoic fluid.  The mice were observed for 10 days and all deaths from influenza were re- 
corded, following which the survivors were sacrificed and their lungs examined for pulmonary 
involvement.  At the time of the intranasal inoculation the test inocnium was titrated in 
four-week-old mice, usually in the dilution range of from 1:10' to 1:107, and the weighted 50 
per cent end-point  was calculated.  Because four-week-old mice are somewhat  more sus- 
ceptible than mice held for an additional 2 weeks, this procedure tends to overestimate the 
actual number of 50 per cent mouse doses.  However, it does serve to provide a standard for 
comparison of the potency of the test inocula used in the different experiments. 
EXPERIMENTAL 
Experimenl A--The first experiment to be described, which was more or less exploratory in 
nature,  differs from the other experiments in t/rot in the tests for immunizing potency the 
intraperitoneal doses consisted of 1 cc. portions of serial one-hundredfold dilutions in 0.1  I, 
sodium-potassium phosphate  buffer instead of 0.5 cc. portions of serial tenfold dilutions in 
0.05 ~, sodium phosphate buffer and in that serial one-hundredfold dilutions of purified active 
virus were used for the test inocuia instead of serial tenfold dilutions of infectious allantoic 
fluids. 
Four lots totaling 1395 ten-day chick embryos were inoculated with PR8 influenza virus 
and following 48 hours' incubation at 36  ° C. and 12 hours chilling at 4  ° the aliantoic fluids were 
harvested.  The four lots of aliantoic fluids,  which totaled 7830 cc., and possessed 260, 201, 
212, and 208 chicken red cell agglutination (CCA) units per oc., respectively, were combined 
and subjected to two cycles of differential centrifugation.  Periods of 15 minutes at 24,000 
R.P.M. were used for the high-speed centrifugation.  The purified material was dissolved in 
202 cc. of 0.1 K phosphate buffer at pH 7 and folbwing clarification at low speed this solution 
was found to contain 2 mg. of protein per cc.  To a 60 cc. portion of this solution was added 
0.15 cc. of a 37 per cent solution of formaldehyde, to a 30 cc. portion was added 0.225  cc. of 
chloroform, and to another 30 cc. portion was added 30 mg. of phenol.  Another 30 cc. portion 
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was left/retreated.  Porti0ns'of each of the five preparations were held at 4* C. and after differ- 
ent i/efiods of time were tested for CCA activity and titered in chick embryos and in  mice. 
Sedimentation constant determinations were made on these preparations  after standing at 
4* C. for 1 week.  Other portions of each of the five preparations were sealed in glass vials and 
frozen in a  COs ice box and still other portions were frozen and dried.  These preparations 
were also tested for CCA activity and titered in chick embryos. 
TABLE I 
CCA Aaivity of Vaccines Containing g Mg. of PR8 Virus  Material per Co. after Being Held 
for Different Periods of Time in Solution at 4 ° C., in a COs Ice Box and in 
the Frozen and Dried State at Room Temperature 
Storage conditions 
4 ° C. in solution 
C01 ice box 
Frozen and dried 
Type of treatment 
0.1 per cent formaldehyde 
0.75 per cent chloroform 
0.1 per cent phenol 
Ultraviolet irradiation 
Untreated 
0.1 per cent formaldehyde* 
0.75 per cent chloroform 
0.1 per cent phenols 
Ultraviolet irradiations 
Untreated 
0.1 per cent formaldehyde§ 
0.75 per cent chloroform* 
0.1 per cent phenol* 
Ultraviolet irradiation* 
Untreated* 
CCA activity 
2 hrs. 
units  I 
per mr.  I 
of prote~- 
3590 
3060 
3240 
2260 
3550 
I days  ]  2wks. 
units  units 
~er rag. i per mr, 
proteinl ~ proteil 
3200  I 
2560  ] 
30501 
1580  ] 
30~  48 
2310  ]  750 
270  30 
1440 
3000 
1300 
2880 
<15 
790 
37 
133 
560 
8 wkS. 
units 
per rag. 
of protein 
3940 
2880 
2850 
1780 
3500 
49 
853 
18 
<2 
565 
5  I 
•  57 
413  I 
15 wks. 
units 
per mr. 
o.¢ protein 
1920 
1970 
3040 
900 
3000 
<1 
277 
35 
1415  486 
3070  1210 
<1 
80 
<1 
<1 
87 
* Contained large amount of insoluble material following treatment and storage. 
Contained small amount of insoluble material following treatment and storage. 
§ Preparation was insoluble following treatment and storage. 
The four treatments did not appear to affect the sedimentation constant of the purified 
virus material, for, in each case, the material was found to show a single boundary in the ultra- 
centrifuge which sedimented at a rate not significantly different from that of the untreated 
material.  The sedimentation constants corrected to water at 20  ° C. but not corrected for 
solution viscosity were found to be 676 S, 688 S, 697 S, 684 S, and 688 S for the untreated, 
formalinized, chloroformized, phenolized, and ultraviolet light-treated materials, respectively, 
at a concentration of 2 nag. per cc.  The fourth of a series of photographs taken at 5 minute 
intervals during sedimentation at 11,100 R.P.M. of the Svensson schlieren diagrams of each of 
the preparations is shown in Figs. 1, 2, 3, 4, and 5, respectively. 
The results of the CCA tests are presented in Table I.  It can be seen that the 
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essentially unchanged, whereas that of the remaining solutions decreased meas- 
urably.  Freezing caused almost complete loss of CCA activity in the cases of 
the formalinized and phenolized preparations and some loss in the cases of the 
chloroform- and ultraviolet light-treated preparations.  A decrease in the CCA 
activity of the untreated frozen preparation was not detected until the test at 
15  weeks.  Freezing and drying caused almost complete loss of CCA activity 
in the cases of formalinized, phenolized, and irradiated preparations, and over a 
70 per cent reduction in CCA activity in the cases of the chloroformized and 
untreated samples. 
The results of the virus activity determinations in chick embryos and in mice 
of the vaccines following storage for different periods of time and under different 
conditions are presented in Table II.  It can be seen that the chloroformized, 
phenolized, and:untreated solutions held at 4 ° C. were essentially fully active, 
whereas the formalinized and ultraviolet light-treated samples were essentially 
inactive.  Freezing appeared to cause about a 90 per cent loss of activity in the 
case of the phenolized vaccine but did not appear to have any further effect on 
the remaining vaccines.  Drying from the frozen state appeared to result in a 
90 to 99 per cent loss of virus activity. 
After standing for 3 days at 4 ° C. or in a  CO2 ice box, the immunizing potency in mice of the 
five vaccines was determined.  The initial intraperitoneal inoculation of 1 cc. portions of the 
untreated samples at the highest concentration tested, 0.2 mg. per ec., was found to result in 
the death of a large number of mice; hence, it was found necessary to administer these inocula 
in two doses of 0.2 cc. and 0.8 cc., respectively, about 3 days apart.  In tl~s experiment in 
which both the vaccine and the test inocula consisted of purified PR8 virus material, as well as 
in all later experiments, the purified material is considered to possess approximately 10  t~ 50 
per cent chick embryo doses and approximately  10  ~050 per cent weighted mouse doses per gram 
of protein.  In each test the three lots of mice were vaccinated with a total of 4 X  10  -~, 4 × 
10  -s, and 4 ×  10  -s gin. of material, respectively, and were tested with active virus at concen- 
trations of 10  -t, 10  -~, and I0  -7 gin. per cc. respectively.  It can be seen from the results pre- 
sented in Table III that all five vaccines held in solution at 4 ° C. possessed about the same 
immunizing potency.  All protected against 50 mouse doses at all three levels of vaccination 
but protected against 5000 mouse doses only following vaccination with the equivalent of 
4,000,000 mouse doses.  None of the vaccines was found to protect against 500,000 mouse 
doses.  The results obtained with the vaccines that had been frozen in a COs ice box were simi- 
lar except that in most instances there was an indication  that the immunizing potency had been 
decreased somewhat by the freezing process.  The indication of a decreased potency was espe- 
cially marked in the cases of the formalinized and phenolized vaccines, for vaccination with 
the equivalent of 400 mouse doses failed to protect the mice against intranasal inoculation 
with 50 mouse doses.  It can be seen from Table I that these two vaccines were the only ones 
which showed large initial losses in CCA activity on freezing. 
As a  whole the results indicate that suitable inactivation of influenza virus 
for the preparation of vaccines can be accomplished by the use of formaldehyde 
or ultraviolet light, but not by the use of chloroform or phenol, and more impor- 
tantly, that such inactivation can be accomplished without causing a  measur- 
able decrease in immunizing potency.  The results also provide a definite indi, 198  CONCENTRATED  PUP~rFIED INFLD'ENZA  VIRUS VACCINES 
cation that the freezing of formalinized or phenolized purified vaccines should be 
avoided and at least a  suggestive indication that the freezing of other types of 
purified vaccines should be avoided. 
TABLE II 
Virus Activity of Vaccines Containing 2 Mg. of PRg Virus Material per Co. after Being Held 
for Different Periods of Time in Solution at 4  ° C., in a COs Ice Box and 
in the Frozen and Dried State at Room Temperature 
Storage 
conditions 
4oc. in 
solu- 
tion 
Amount of material giving a 50  [  Amount of material giving 
per cent infectivity end-point  [  a weighted 50 per cent 
Type of treatment  in chick  embryos  end-point in mice 
CO~ ice 
box 
Frozen 
and 
dried 
0.1 per cent 
Ultraviolet ir- 
0.1 per cent 
formaldehyde 
0.75 per cent 
chloroform 
0.1 per cent 
phenol 
Ultraviolet ir- 
radiation 
Untreated 
2 hEs.  3 days 
gm,  gm, 
0.1 per cent  <10  -''s  >10  -s's 
formaldehyde I 
0.75 per cent  I  < 10  -s's  10  -s'8 
chloroform 
10-14.o  l~-l~.s 
phenol 
lO~.0 
radiation 
Untreated  LO  -ta'a  10  -u's 
> 10-14 
> 10-6.. 
lO--g.I 
10-~.s 
>lO-~.s 
10-~.4 
0.1 per cent 
formaldehyde 
0.75 per cent 
chloroform 
0.1 per cent 
phenol 
Ultraviolet ir- 
radiation 
Untreated 
Exp~im~t g.--The results of Experiment  1 provided  an indication  that there might be 
some correlation between CCA activity and immunizing potency.  It should be noted in this 
connection that the CCA activity can be measured with an accuracy of 10 per cent, when neces- 
sary, whereas measurements of immunizing potency are probably far less accurate.  However, 
if a correlation  between  CCA activity and immunizing potency actually  exists, sufficiently 
htrge differences in CCA activity should be reflected in measurable differences in immuni~ng w.  ~.  STA~_~Y  199 
TABLE III 
Immunizing Potency in Mice of Di.~erer~ Vaccines Containing 2 Mg. of PR8 Virus Matoqal : 
1~er Co. 
Mice vaccinated  twice intraperitoneally a week apart 
with 1 Cc. portions equivalent to total dosages listed 
below 
Mice not 
vaccinated 
4 X  10-~ gin.  4 X  10  ~  gin.  4 X 10-s gm. 
or 4,000,000 mouse  or 40,000 mouse  or 400 mouse 
doses  doses  doses 
D,,$D=,D=,D=,I 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
D,, D,,D=,D,,D, 
1,  0,  0,  0,  0 
0,  0,  0,  0,  0 
D,, D2,D,,D=,De 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
D,, D,,Ds,D,,0 
0,  0,  0,  0,  0 
0,  0,  0,  0,  M 
D,, D,,DJ,0,  0 
0,  0,  0,  0,  0 
0,  0,  0,  0,  M 
D,, D,,D,,D,,D, 
Dh Ds,0, 0, 0 
O,  O,  O,  O,  0 
Ds, Dt,D,,D,,0 
D=, D,,0,  0,  0 
0,  0,  0,  O, 0 
D=, Ds,Dt, Dt,Da 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
D,, D=,D~,D,.0 
D4, D,,0,  0,  0 
0,  0,  0,  0,  0 
D=, D2,D2,D=,M 
D2, D2,0,  0,  0 
D,, 0,  0,  0,  0 
D~,Ds,D~,De,Ds 
D:,D,,De,0,  0 
0,  0,  0,  0,  0 
D=,D=,D,,D,,0 
1,  1,  0,  0,  0 
0,  0,  0,  0,  0 
D,,D,,D,,D,,0 
D,,De,0,  0,  0 
0,  0,  0,  0,  0 
DhDe,De,M, M 
D=,D,,De,I,  0 
0,  0,  0,  0,  0 
D,,D=,D,,D,,D, 
D=,D2,De,0,  0 
0,  0,  0,  0,  0 
D=,D,,D,,I,  M 
D,,D,,D,,0,  0 
0,  0,  0,  0,  0 
Da,D,,D,,D,,O 
D,,D,,D=,D,,D, 
0,  0,  0,  0.  0 
D,,D~,D=,D,,D, 
D,,D,,DI,I,  0 
0,  0,  0,  0,  0 
D,,D,,D,,D,,D, 
D=,Dj,DI,0,  0 
0,  0,  0,  0,  0 
D,,D,,D=,D,,D, 
D2,1,  l,  0,  0 
0,  0,  0,  0,  0 
D2,D2,1,  0,  0 
D~,I,  l,  I,  0 
1,  1,  1,  0,  0 
D=.D,,D,,D,,D, 
D2,Dh0,  0,  0 
I,  0,  0,  0,  0 
D=,Dz,D,,D,,0 
Dr, l,  1,  1,  1 
0,  0,  0,  0,  0 
D,,D,,D,,D,,D, 
Da,D,,DI,o,  0 
D7,1,  1,  (3,  0 
D~,D,,Ds,0,  M 
DhDI,1,  1,  0 
1,  0,  0,  0,  0 
DhD~IDs,D,,D, 
D=,D,,D4,D~,I 
D4,Dj,D,,D*,0 
D,,D,,D,,D4,D, 
D,,D2,Ds,0,  0 
Di,0,  0,  0,  0 
D,,D,,1,  I,  M 
D,,Ds,D,,D6,3 
DI,D¢,D;,3,  1 
D=,D,,D=,M, M 
D4,D4,DI,DT,1 
D,e,0, 0,  0,  0 
D=,D,,D,,D,,D, 
D=,D,,De,DI,,0 
0,  0,  0,  0,  0 
D,,D,,D,,D,~D, 
D,,D,,D,,D,,Ds 
DI,D6,DhDs,2 
D~,D:,Ds,D,,D, 
D:,D2,D:,Ds, DJ 
D4,DnDI,D*,Dt 
* This preparation  of purified  PR8  virus material was found to have a  weighted 50 per 
cent end-point in 4-week-old  mice at  10  -0.0  gin.  of  protein  at  the  time  of  administration 
of the test doses. 
In this and in  the following similar tables the mice which died are listed as D, witha 
subscript denoting the day of death.  The degree of pulmonary involvement in theanimals 
surviving on the 10th day is indicated  by numerals, with 4  =  lung completely consolidated, 
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potency.  It appeared  worthwhile, therefore,  to compare the immunizing potency  of the 
frozen, and of the frozen and dried formalinized vaccines, described in Experiment 1 which 
possessed less than I  CCA unit per rag. of protein, with that of the frozen ultraviolet light- 
treated vaccine of Experiment 1 which possessed  486  CCA units per rag. of protein after 
standing for 15 weeks.  In addltion, there was included, for purposes of comparison, a prepara- 
tion of purified PR8 virus material which had been inactivated by standing at pH 4.8 for some 
time at4  ° at a concentration of 2 rag. per cc.  This material, which originally possessed  2800 
CCA units per rag. of protein, was found to possess only 67, 34, 18,.and 1 CCA units per rag. 
of protein after standing at pH 4.8 for 3 hours, l, 2, and 12 days, respectively.  It was titered 
in chick embryos at the end of the 12 day period and found to possess a 50 per cent infectivity 
end-point at more than 10-~  gin. of protein.  It is interesting to note that another portion of the 
same virus preparation which was held under the same conditions except at pH 3.2 was found 
to possess  64, 44, 37, and 45 CCA units per rag. of protein, respectively, at the end of similar 
periods of time.  These results indicate that at hydrogen ion concentrations near or more acid 
than the isoelectric point of the virus material there is an immediate loss of about 98 per cent 
of the CCA activity but that the residual activity is more stable at pH 3.2 than at pH 4.8. 
The immunizing potency in mice of the four preparations just described was determined by 
means of two intraperitoneal doses, 8 days apart, of 0.5 cc. portions containing 10"4, 10  -~, 10-~ 
and l0  -~ gin. of material per cc. followed, 8days later, by test doses of appropriate dilutions of 
infectious PR8 allantoic fluid.  It can be seen from the results which are presented in Table IV 
that the frozen and dried formalinized preparation having less than 1 CCA unit per rag. of 
protein possessed no immunizing potency and that the frozen formalin!~d preparation gave 
only a small amount of protection to the mice.  The acid-inactivated sample and the frozen 
ultraviolet light-~reated sample, which possessed  about 20 and 485 CCA units per rag. of pro- 
rein, respectively, provided somewhat better protection to the mice. 
As a  whole, the results indicate that there is at least a  rough correlation 
between CCA activity and immunizing potency. 
l~xperiment 3.--It has been noted in experiments conducted with Dr. C. A. Knight that 
purified PR8 virus preparations at a concentration of 0.1  mg. per cc. lost chick embryo and 
CCA activities rapidly on irradiation with ultraviolet light and that the rate of loss of embryo 
infectivity was greater than that of CCA activity.  It appeared desirable, therefore, to deter- 
mine the rates of loss of these activities at other concentrations of virus and especially to 
compare  the  immunizing potency  of  an  irradiated  preparation  having considerable  CCA 
activity with that of an irradiated preparation having no demonstrable CCA activity.  Ac- 
cordingly, a portion of a preparation of purified PR8 virus at a concentration of 9 rag. per cc. 
was diluted with 0.1 M phosphate buffer at pH 7 to give a solution containing 1 rag. of virus 
material per cc., and 2 cc. portions of this solution as well as 2 cc. portions of the original solu- 
tion were placed in small porcelain dishes 5~ inches in diameter at the bottom and about 1 
inch in diameter at the top.  These dishes were placed under a  Sterilamp in such a manner 
r  1  that the upper surfaces of the liquid layers, which we e ~  inch in depth, were 4 inches from the 
tube of the lamp.  The solutions were irradiated for the periods of time listed in Table V and 
each solution was stirred twice during each time period.  The temperature of the liquid was 
25  ° at the start of the experiment and 27.5 ° at the end of 4 hours' irradiation.  Immediately 
following the designated periods of irradiation the samples were removed, placed in sterile test 
tubes, and tested for CCA and virus activities. 
It can be seen from the results presented  in Table V that in each  case  the 
rate of loss of virus activity greatly preceded that of CCA activity and, more 
importantly,  that the greatest decrease in virus activity with the least change TABLE  IV 
Immunizing  Potency in Mice of Vaccines  Containing  2 Mg.  of PR8 Virus Material per Cc.. 
and Possessing  Different  CCA Acti~ties 
Mice vaccinated  twice intraperitoneally 8 days apart with 0.5 cc. 
portions equivalent to total dosages listed  below 
oo  per 
Nature of vaccine  cent 
mou$~ 
doses  10  -~ gin.  or 
1,000,000 mouse 
•  in  doses 
Inocu- 
lum 
Frozen and dried for-  240,00(  D,,D=,Da,Dt,D, 
malinized  prepara-  24,00( D4,D~,Dt,De,D4 
tlon  of  Exp.  1  <1  2 400' D~,Dt,  De,D,,0 
CCA unit per mg. of  240  D~,D~,3,  1,  0 
protein 
Frozen  formalinized  240,000 D2,Ds,Ds,D,,3 
preparation of Exp.  24,000 D=,Ds,D4,2, 0 
!  <1  CCAunit per  2,400 0,  0,  0,  0,  0 
rag. of protein  240  0,  0,  0,  0,  0 
Purified PR8 virusma-  240,000  D=,D=,D~,Ds,Dt 
terlalinactlvatedat  24,000  0,  0,  0,  0,  0 
pH4:8,  ca. 20 CCA  2,400 0,  0,  0,  0,  0 
unitspermg, ofpro-  240  0,  0,  0,  0,  0 
teiu 
Frozen ultraviolet  Jr-  240,000  Ds,  D=,D=,D=,I 
radiated preparatlon  24,000  1,  1,  0,  0,  0 
of Exp.  1 486  CCA  2,400 0,  0,  0,  0,  0 
units per rag. of pro-  240  0,  0,  0,  0,  0 
teiu 
Unvaccinated  240,000 Ds,  D2,D=,Di,D, 
24,000  Di,Di,D4,D~,De 
2,400  D~,D~,DT,Ds,3 
240  D~,D,,De,De,3 
I  I0-~ gin. or  100,000 mouse 
doses 
D=, DI,D,,Da,Ds 
Ds, D4,DhDe,I 
D,, DhDT,3,  1 
D~, De,l,  0,  0 
Ds, D,,D,,D:,D, 
D=, Dt,D,,D,,I 
Die, l,  1,  0,  0 
DT, Dj,0,  0,  0 
D2, Ds,Ds,Ds,D2 
Dr, Ds,I,  I,  0 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
Ds, Ds,D2,Dt,Ds 
D4, D4,D,,De,D, 
1,  0,  0,  0,  0 
0,  0,  0,  0,  0 
10  ~  gln. or 
10,000 mouse 
doses 
D,,D2,Ds,Dt,D, 
D,,D,,D,,D6,DI 
D4,D4,D6,DT,D7 
Dj,D,,D,,Ds,3 
Ds,D=,De,D,,De 
Dt,Di,Dh2  1 
De,D4,3,  2,  1 
3,  0,  0,  0,  0 
Ds,D,,D=,D=,D4 
Dhl,  0,  0,  0 
D4,2,  0,  0,  0 
0,  0,  0,  0,  M 
Dt,Dt,Dt,Ds,D= 
D,,Di,D,,DI,  I 
De,0,  0,  0,  0 
I,  0,  0,  0,  0 
10  -7  gin. or 
1,000 mouse 
doses 
D,,Dt,D,, Dr, D4 
D,,Dt,D,, De, Dr 
De,De,De, Dis,3 
D4,DT,DIs,3,  1 
Dt,D,,D,, De, Ds 
D=,D,,D4, D4, D4 
D4,Dj,D7,2,  0 
DT,DT,De, Ds, Dt 
D2,D=,Ds, Ds, De 
D=,2,  1,  0,  0 
D4,DI,0,  0,  0 
0,  0,  0,  0,  0 
J 
Ds,  Ds,  D=, Ds,  Da 
D2,D,,De, D4, Ds 
De,De,  DT, Dr, 0 
DI,DT,2,  1,  t 
* This  PR8  allantoic  fluid  was found  to  possess 220  CCA  units  per cc.  and  to  have  a 
weighted  50  per cent  end-point  in 4-week-old  mice at  a  dilution  of  i:106"as at  the  time  of 
administration of the test doses. 
TABLE  V 
CCA Aaivity and Chick Embryo Activity of Preparations Containing  I  and 9 Mg. of  Puri.f~d 
PR8 Virus Material per Co. in 0.1 x  Phosphate  Buffer at pH 7 Following 
Irradiation with Ultraviolet Light for Different  Periods  of Time 
Time of irradi~tioa 
m/n. 
0 
15 
30 
6O 
120 
240 
1 rag. purified PR8 virus material per cc. 
CCA activity 
units per mg. of 
~oUin 
2975 
2230 
5O6 
<1 
<1 
50 per cent chick 
embryo infectivity 
end-point 
&m. of protein 
10-1a4 
>10--4 
>10-~ 
>10"-~ 
9 nag. purified FR8 virus material per cc. 
CCA activity 
units per rag. of 
protein 
2975 
2550 
2430 
1830 
435 
50 per cent chick 
embryo infectivity 
end-point 
gin. of prolein 
10-u.s 
10-s.~ 
l O-S.2 
10-~., 
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in CCA  activity was achieved with the virus preparation at a concentration  of 
1 mg. per cc.  Irradiation of the preparation containing  1 mg. of material per 
cc. for only 15 minutes was sufficient to destroy the virus activity and yet this 
treatment caused only a small decrease in CCA activity. 
The immunizing potency in mice of the preparation containing 1 rag. of protein per cc., 
which following irradiation for 60 minutes possessed  no demonstrable chick embryo or CCA 
TABLE  VI 
A  Comparison of the Immunizing Potencies of UItraviole~ Ligl~ Irradiated PR8 Virus Vacfines 
Possessin  2430 and Less than I CCA  Unit, Respecti~dy, per Mg. of Protein 
Nature of vaccine 
[rraAiated with ultra- 
violet light and pos- 
sessing  2430 CCA 
units  per  ms.  of 
protein 
Irradiated with ultra- 
violet light and pos- 
sessing less than 1 
CCA unit per rag. of 
protein 
Unvaccinated 
Test 
dose* 
No. of 
50 per 
cent 
mouse 
doses i~ 
inoeu- 
lure 
44,0001 
4,400 
440 
441 
44,000 i 
4,400 ! 
440 I 
44 ' 
44,000  [ 
4,400 
440 
44 
Mice vaccinated twice intraperitoneally 8 days apart with 0.5 cc. portions 
equlvalent to total dosages listed below 
! 
10-4 gin. or  i 
1,000,000 mouse 
doses 
D,,D,,D,,Ds,2 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
D,,Ds,D,,D,,0~ 
D,,Ds,2,  1,  0 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
De,Dt,Ds,D,,Dt 
D,,Dt,D6,D*,DI 
DJ.Ds,DT,DT,2 
D7,2,  2,  2,  t 
10-6  gra. or 
I00,000 mouse 
doses 
D,, D,,Dt,Ds,2 
D,, D,,I,  1,  1 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
D,, D,,D,,Ds,D, 
D4,1,  1,  1,  0 
Dt~,l,  0,  0,  0 
0,  0,  0,  0,  0 
10  -= gra. or 
10,000 mouse 
doses 
D,,D,,D,,D,,M 
D,,D,,D,,D4,0 
1,  1,  0,  0,  0 
0,  0,  0,  0,  M 
D,,D,,D,,Dt,Ds 
D4,2,  2,  1,  1 
I,  1,  0,  0,  0 
0,  0,  0,  0,  0 
10  -7 gin. or 
1,000 mouse 
doses 
D,,D,,D,,D,,2 
1,  1,  1,  0,  0 
1,  0,  0,  0,  0 
0,  0,  0,  0,  0 
D,,D,,D,,Ds,I§ 
Ds,D4,Ds,DT,D= 
2,  2,  1,  l,  0 
2,  1,  1,  I,  0 
* This PR8  allantoic fluid was found to possess 272  CCA units per cc. and  to have a 
weighted 50 per cent end-point in 4-week-old mice at a  dilution of 1:10 ~'64 at the time of 
administration of the test doses. 
:~ Three mice immunized at the same time but tested 20 days later with the same inoculum 
gave readings of Ds, D4, and D4. 
§ Four mice immunized at the same time but tested 20 days later with the same inocuhim 
gave readings of D=, Ds, D~, and D4. 
activity, was compared with that of the preparation containing 9 rag. of protein per cc., which 
following irradiation for :60 minutes possessed 2430 CCA units per rag. of protein and a 50 per 
cent infectivity end-point in chick embryos at 10  -s'l gin. of protein.  It can be seen from the 
results presented in Table VI that the immunizing potency of the preparation possessing 2430 
CCA units per rag. of protein was measurably superior to that of the preparation possessing 
no CCA activity.  It seems unlikely that this difference can be due to the small residual virus 
activity possessed by the former preparation since the amount of this activity, even at the 
highest dosage level administered, was only about one 50 per cent mouse dose. 
The results obtained with the irradiated vaccine listed in Table III, together 
with the results just described and those of other investigators (47), provide w.  ~.  STAm~E~  203 
evidence that fully potent non-infectious influenza vaccines can be prepared 
by ultraviolet light irradiation, but that too much irradiation can  result  in  a 
decrease in immunizing potency.  These results provide a practical approach 
for  the  preparation  of  irradiated  influenza virus vaccines for they indicate 
that fully potent vaccines can be obtained by the administration of an amount 
of irradiation sufficient to cause loss of virus activity but insufficient to cause 
a  marked decrease in CCA activity and that this can be accomplished satisfac- 
torily at a  concentration level  of about  1  mg.  of virus material per cc. 
Experimen~ 4.--In view of the results obtained on exposure of PR8 influenza virus to differ- 
ent amounts of ultraviolet irradiation it appeared necessary to determine the m~n~mum con- 
TABLE VII 
CCA and Ctdck Embryo Activities of Purified PR8 Virus Material at 1 and 10 Mg. per Cc. Containing 
Different Amounts of Formaldehyde after Standing at 4 ° C. in 0.1 ~  Phosphate 
Buffer for Periods of Time Listed Below 
Concentra-  Concen- 
tion of  tration 
p~rified  of 
virus  formal- 
material  dehyde 
rag. protein  per 
per co.  cent 
0.00 
0.05 
10  0.10 
0.20 
1.00 
0.00 
0.01 
1 
0.05 
0.10 
CCA activity 
lday  ....  2days 4days  l mo. 
units  units  units  units 
per  per  per  per 
mg. of  mg. of  mg. of  mg. of 
protein protein protein  protein 
3200  257C[  2510 
3070  299C] 3310  2720 
i 
3020  3280  3200  3340  i 
3170  3130i 3240  346(} 
2690  247C: 1790  1620 
i 
2910  13200 
3470  32201 3130 
3080  289C  3070 
2800  2630  2410 
6  r/lOS 
units 
per 
m~. o/ 
protein 
334( 
200( 
256g 
156( 
28£ 
278( 
Amount of material giving  a 50 per cent infectivity 
end-point  in chick  embryos 
4 days  1 day  2 days 
ggPL  gm. 
i0-14 
> 10-10.=  > lO-S.2 
10--s.2  ~ 10-7.2 
10-s.2  ~ 10-s.2 
10-7.2  ~ 10-s.2 
10-1. 
10-11.~  10-s.7 
10  -g-~  10-7.= 
>  i0-s.2  10-6.~ 
1 too.  i  6 mos. 
Z~S.  g'm.  i 
i0.-18.~: 
10-4.2  10~.1  ~ 
10-4.~  10-4.=  , 
10--4.2  10-~.2 
10  -~.~  >  10-~-2 
i 
10-1, a 
10-4.2 
10-4.~ 
10-4.2 
lO-U.S 
10-ms 
centmtion of formaldehyde that is required to cause suitable inactivation of virus and also the 
concentration that will cause measurable changes in CCA activity.  Accordingly, aliquots of 
solutions of purified PR8 virus material in 0.1 ~ phosphate buffer at pH 7 containing 1 and 10 
rag'. of protein, respectively, per cc. were treated with different  concentrations  of formaldehyde 
and the CCA and chick embryo activities were determined  following  standing at 4  ° for different 
periods of time.  It can be seen from the results presented in the bottom half of Table VII 
that even 0.01 per cent formaldehyde in a solution containing 1 rag. of virus material per cc. 
was sufficient to cause a reduction in chick embryo titer from 10  -14 gm. to 10-~-~  gin. in 4 days. 
This concentration of formaldehyde, as well as a  concentration five times greater, did not 
appear to affect the CCA activity after 4 days, but there was indication that a concentration 
of 0.1 per cent formaldehyde causes a decrease in CCA activity of virus material at a concen- 
tration of 1 rag. per cc.  This result is similar to that obtained in Experiment 1 in which 0.1 
per cent formaldehyde in a solution containing 2 rag. of virus material per cc. resulted in a 
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The results given in the upper half of Table VII indicate that during a period 
of 1 month 0.05, 0.1, and 0.2 per cent formaldehyde in the presence of 10 rag. 
of virus material per cc. causes suitable inactivation of virus without altering 
the CCA activity.  However at the end of 6 months the formalinized prepara- 
tions  showed  significant decreases in  CCA  activity and  this  was  especially 
marked in the case of 1.0 per cent formaldehyde.  As a whole, the results with 
formaldehyde demonstrate that suitable inactivation of virus without marked 
TABLE  VIII 
Immunizing Potency in Mice of a Vaccine Containing 2 Mg. of Purified PEg Virus Material 
per Cc. and 0.I Per Cent Formaldehyde after Standing for 2 Months at 
4 °, 18-Z5  °, and 37  ° C.,  Respeaivdy 
Storage 
conditions 
4" C. 
18 
to 
25* C. 
37" C. 
Unvscclnsted 
Test dose* 
No. of 50 
per cent 
mouse 
doses  in 
inoculum 
80,000 
8,000 
80O 
8O 
$0,000 
8,000 
$0O 
8O 
80,000 
8,000 
8OO 
80 
80,  000 
8,000 
800 
80 
$ 
Mice vaccinated twice intraperltoneally 8 days apart with 0.5 cc. portions 
equivalent to total dosages listed below 
10  "4 gin. or 
1,000,000 mouse 
doses 
Dr,Dr,Dr,2,  1 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
Dt,Ds,D,,Dt,Dt 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
O,  O,  O,  0,  0 
D,,I,  1,  1,  M 
Dr,0,  0,  0,  0 
0,  0,  0,  0,  M 
0,  0,  0,  0,  M 
Dt,Dt,  D~Dt,  D~ 
Da,  D*,D4,Dt,Dz 
D,,D,,D~,3,  2 
DT, D~,DT, DT,D, 
D6,DT,DT,3,  2 
IO'-S gin.  or 
I00,00O  mouse 
doses 
D2,Dt,Dt,D2,D~ 
Dr,0, 0,  0,  0 
0,  0,  0,  0,  0 
0,  0,  0,  O,  0 
Dr,Dr,Dr, I,  M 
Dr,Dr,l,  1,  1 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
DI,Ds,DI,Ds,D~ 
I)t,0,  0,  0,  0 
1,  0,  0,  0,  0 
0,  0, 0,  0,  0 
10  -6 gin. or 
10,00O mouse 
doses 
Dt,Dz,Ds,Dt,DI 
1,  1,  I,  1,  0 
I,  0,  0,  0,  0 
1,  0,  0,  0,  0 
D2,Ds,Dt,Dt,0 
D~,Dt,1,  1,  1 
D4,1,  0,  0,  0 
0,  0,  0,  0,  0 
Dt,D,,Dj,D,,2 
D:,D,,I,  0,  0 
Ds,1,  0,  0,  0 
0,  0,  0,  0,  0 
10-7 gin. or 
1,000 mouse 
doses 
Dt,Ds,D2,Ds,D~ 
Ds,D~,I,  0,  0 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
DI,Dt,Da, D4,2 
D4,D4,D6,2,  1 
DT,Dv,3,  1,  0 
Ds,0,  0,  0,  0 
Dt,Dt,Dt,D,,D, 
D2,Dt,D,,1,  0 
D4,De,DT,2,  1 
D,,D4,1,  0,  0 
* This PR8  aUantoic fluid  was found to possess 123 CCA  units per cc. and to have a 
weighted 50 per cent end-point in @week-old mice at a dilution of 1:104"g  at the time of 
administration of the test  doses. 
effect  on  CCA activity  can  be  achieved over  a fairly  wide  range  of  formaldehyde 
concentration. 
Exp~,iment 5.--The stability  of the immunizing potency of a formalinized PR8 virus  vac- 
cine  following  storage  at  different  temperatures was studied by holding aliquots  of  the  solution 
of fornmlinizcd vaccine,  described in  Experiment i,  at  4  °, 18-25  °,  and at  37  °,  respectively,  for 
2 months and determining the comparative immunizing potencies of the three preparations. 
In addition,  the CCA  activities  of the three preparations were determined at the end of 2, 4, 
and 6 months of  storage.  It  canbe seen from the  results  presented in  Table VIII that storage 
at 18-25" and at  37  °  resulted  in  a measurable deterioration  of  immunizing potency.  Vaccina- 
tion  of mice with 10  -7  gin.  of  the material held at  4  °  protected against  80 and 800 weighted 50 w,  M.  STAI~r.Y  205 
per cent mouse doses, whereas from 10  "~ to 10  "~ gin. of the materials held at the higher temper- 
atures were required for similar protection of mice.  A comparison of the results recorded 
in Table VIII for the solution held at 4  ° with those listed in Table HI for the same material 
at the start of the experiment indicates that no measurable loss in immunizing potency oc- 
curred on storage for 2 months at 4  °. 
The results of the CCA tests following storage for different periods of time at 
different temperatures are presented in Table IX.  It can be seen that at 4 ° a 
measurable decrease in CCA activity had taken place by the end of 4  and 6 
months.  At 18°to 25°and at 37  ° the decrease in CCA activity was noticeable 
at 2 months and was quite marked at 4 and 6 months.  It is possible that the 
relatively high concentration  of formaldehyde of 0.1 per cent with 2 rag. of virus 
material per cc., which was used in this vaccine preparation, may have  been 
responsible for part of the decrease in CCA activity.  As can be seen from the 
TABLE IX 
CCA  Aai~i~y  of a  Vaccine  Corgaining 2 Mg. of Purified PRg  Virus Material #er Co. and 
0.1 Per Cent Formaldehyde after Slanding for Different Periods of 
Time at 4 °, lg-25 °, and 37  ° C., Respecli~dy 
CCA activity 
Storage conditions 
At start  2 mos.  4 mos.  6 mos. 
4 °  C. 
18-25  ° C. 
37  ° C. 
units per rag. of 
protein 
3500 
3500 
35OO 
units per fag. of 
protein 
3860 
2310 
1260 
units per fag. of 
protein 
1920 
57O 
35O 
units per fag. of 
protein 
1500 
7 
81 
results of the preceding experiment, this concentration of formaldehyde is con- 
siderably higher than is necessary to secure suitable inactivation  of virus.  It is 
possible that a  formaldehyde concentration of considerably less than 0.1  per 
cent will be found to be much more suitable for vaccines containing influenza 
virus material at concentration levels near 1 mg. per cc. 
~xperiment 6.--In order to secure a relationship between the present purified and con- 
centrated vaccines and vaccines that have been used earlier for the immunization of man and 
animals a comparison was made of the immunizing potency in mice of three different prepara- 
tions.  The first consisted of the solution containing 2 rag. of purified PR8 virus material 
per cc. and 0.1 per cent formaldehyde described in Experiment 1; the second was a sample of 
freshly harvested untreated infectious PR8 allantoic fluid; and the third was a preparation 
of three strains of influenza virus purified and concentrated by the red cell elution method. 
The latter material, which was kindly supplied by Dr. T. Francis, Jr., represents a portion 
of the vaccine that was used extensively in tests in man (39).  Although each cubic centi- 
meter of this vaccine represents the amounts of Lee, PRS, and Weiss virus materials obtained 
from 5, 2.5, and 2.5 cc. of the respective infectious ailantoic fluids, the actual amounts of th¢ 
three virus materials present in the vaccine are'unknown  because of uncertainties  regarding 
the recovery of virus  by the red cell elution method.  In order to gain some idea of the approxi- 206  CONCENTRATED  PURIFIED  INFLUJ/~NZA VIRUS  VACCINES 
mate amount of virus material present, 15 cc. of the vaccine were  subjected to purification 
and concentration by differential centrifugation.  The original vaccine was found to  possess 
470 CCA units per cc. and to contain 0.11  ms. of protein  nitrogen per ec.  of which 0.01  rag. 
was removed on centrifugation at low speed.  The clarified solution containing 0.10 rag. of 
TABLE  X 
Comparison of the Immunizing Potency of Formalinized Purified PR8 Virus MaZerial, Untreated 
PR8 Allantoic Fluid, and a Vaccine Prepared by the Red Cdl Elution Method 
Nature of 
vaccine 
Purified PR8 
virus material 
at 2 mg. per cc. 
and 0.l 
formaldehyde 
Untreated PR8 
Vaccine' 
by red cell elu- 
tion method§ 
Unvaccinated 
Mice vaccinated twice intraperltoneally 8 daysapart with 0.5 cc. portions 
equivalent to total dosages listed below 
rmoase 
doses in  10-4 gra. or  104 gin. or 100,000 
1,000,000 mouse  mouse doses  inoculum  doses 
160,000  D2,D2,D~,D2,DI  D2,Ds,  D~,D2,Ds 
16,000  D:,0,  0,  0,  0  D2,Ds,DhDhl 
1,600  0,  0,  0,  0,  0  1,  0,  0,  0,  0 
160  0,  0,  0,  0,  0  0,  0,  0,  0,  0 
Undiluted or  1:10 dilution 
5,000,000 mouse  or 500,000 mouse 
doses  doses 
160,000  Ds,Ds,Ds,Ds,D,  Ds,Ds,Dt,Ds,D2 
16,000  D~,0, O,  0,  0  D~,D~,D~,0,  0 
1,600  0,  0, 0,  0,  0  D,,0,  0,  0,  0 
160  O,  O,  O,  O,  0  2,  1,  0,  0,  0 
Undiluted or  1:I0 dilution 
1,000,000 mouse  or 100,000  mouse 
doses  doses 
160,000  Ds,  D~,D~,D~,D~  Ds,D~,D~,D~,D~ 
16,000  D2,DI,D~,D~,D~  D~,D~,D,,Ds,Ds 
1,600  Ds,0,  0,  0,  0  0,  0,  0,  0,  0 
160  0,  0,  0,  0,  0  0,  0,  0,  0,  0 
160,000  Ds,Ds,D,,Ds,D, I 
16,000  D~,D,,D~,D,,Dt 
1,600  DI,DI,De,De,D7 
160  De,D6,DT,DT,3 
104 gin. or 10,000 
mouse doses 
Ds,Ds,Ds,Ds,Dj 
Ds,Di,D4,1,  0 
1,  I,  1,  O,  0 
1,  1,  1,  0,  0 
1:100 dilution 
or 50,000 mouse 
doses 
D~,D~,Ds,Ds,D2 
Ds,D~,D,,D~,0 
O,  O,  0,  O,  M 
0,  0,  0,  0,  0 
I: 100 dilution 
or 10,000 mouse 
doses 
D2,D~,D2,D2,1 
D~,Ds,DI,D4,2 
0,  0,  0,  0,  0 
O,  O,  O,  O,  0 
10  ~7 gin. or 1,000 
mouse doses 
D2,D2,D2,Ds,Ds 
D2,D2,3,  2,  1 
1,  I,  0,  0,  0 
1,  0,  0,  0,  0 
I: 1000 dilution 
or 5,000 mouse 
doses 
D2,D~,D:,,D2,I 
D2,Dhl,  0,  0 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
1:1000 dilution 
or ls000 mouse 
doses 
D2,D2,D,,D2,D2 
Da,Dt,D4,D,,I 
Ds,Di,1,  i, 0 
De,l,  1,  1,  0 
* This PR8  allantoic  fluid was found to possess 249  CCA units per cc.  and  to have a 
weighted 50 per cent  end-point in 4-week-old mice at a  dilution of  1:105"s at the  time of 
administration of the test doses. 
This PR8  allantoic  fluid was found to possess 222  CCA  units per cc.  and  to have a 
weighted 50 per cent  end-point in 4-week-old mice at a  dilution  of  1:105"4 at the  time of 
administration of the first vaccination. 
§ Kindly supplied by Dr. T. Francis, Jr., and used about 8  months after preparation. 
protein nitrogen per cc. was centrifuged at 24,000 R.P.~. for 15 minutes and the supemstant 
liquid was found to contain 8 CCA units and 0.08 rag. of protein nitrogen per cc.  Of the 0.02 
nag.  of protein nitrogen per cc., which was sedimented, 0.014  rag. was found to be soluble. 
This fraction possessed 2700 CCA units per rag. of protein and, at a concentration of 2.1  ms. 
per cc., gave a rather diffuse boundary in the,analytical centrifuge with a sedimentation con- 
stant of about 700 S.  The fourth of a series of photographs taken at 5 minute intervals during w.  M.  STANI.V.Y  207 
sedimentation at 11,100 R.P.~.  of the Svensson schlieren diagrams of this material is shown 
as Fig. 6,  The actual isolation by differential centrifugation of 0.14  mg. of protein per cc. 
of vaccine can be regarded as an indication that the vaccine contains approximately 0.2 rag. 
Of virus material per cc.  For purposes of the present experiment it was assumed that one-haft 
of this material, or 0.I rag. per cc., is Type A virus material and, hence, that I cc. of the vaccine 
represents the equivalent of I0  s weighted mouse doses of Type A virus. 
It can be seen from the results presented in Table X  that there is little differ- 
ence in immunizing potency of 0.1 rag.  of formalinized purified PR8 virus ma- 
terial, I  cc. of undiluted infectious PR8 allantoic fluid, and  i  cc. of the vaccine 
prepared by the red cell elution method and the corresponding dilutions of these 
preparations. 
There is some indication that the protection afforded by the red cell vaccine against PR$ 
virus was somewhat less secure than that provided by the other two materials, since all five 
mice vaccinated with 1 cc. of the undiluted red cell vaccine died following intranasal instillation 
of 16,000 weighted mouse doses, whereas only one of five mice died in each of the two com- 
parable groups vaccinated with 1 cc. of undiluted allantoic fluid or with 0.1 rag. of formalinized 
purified PR8 virus.  Similarly, of the mice vaccinated with 1 cc. of a  1 : 1000 dilution of the 
red cell vaccine, two died following the administration of 1600 weighted mouse doses whereas 
none of the mice died in comparable groups  vaccinated with the other two materials.  How- 
ever, it is difficult to be certain that such differences are significant due to uncertainties in the 
actual amounts of virus material present in the red  cell vaccine and in the allantoic fluid. 
The resuits do indicate that the immunizing potency of the red cell vaccine against active PR8 
virus is not greater than that of untreated  PR8 allantoic fluid of good potency or purified 
PR8 virus material at a concentration of 0.1  rag. per cc.  This  result is in accordance with 
expectation since in each instance the amount of immunizing antigen administered  was es- 
sentially the same. 
The results demonstrate that the 95 per cent of extra~neous protein present in 
infectious allantoic fluid and the 80 per cent of extraneous protein present in the 
red cell vaccine are not necessary for the effective immunization of mice. 
Experiment 7.--In order to determine, by means of  clinical tests, the optimum amount 
of influenza virus necessary to produce optimum protection in man, it appeared that it would 
be necessary to prepare a  much more concentrated polyvalent vaccine than any heretofore 
prepared.  The vaccines described earlier in this report contained 2 rag. of PR8 virus material 
per cc. or an amount of immunizing antigen approximately ten times that contained in the 
vaccine, prepared by red cell elution, which was used in extensive tests in human beings and 
demonstrated  to afford considerable protection against  the natural  disease  (39).  In order 
to increase the probability of securing a  concentration greater than that actually required 
for the optimum protection in man, a polyvalent vaccine containing 10 rag. of virus material 
per cc. was prepared and subjected to laboratory tests.  Lee, PRS, and Weiss virus materials 
produced in chick embryos and  concentrated and  purified by means of two cycles of dif- 
ferential centrifugation were used in this vaccine.  To 14 cc. of 0.05 ~ sodium phosphate solu- 
tion at pH 7 containing 140 mg. of purified Lee virus material were added 7 cc. of a similar 
solution containing 70 rag.of purified PR8 Virus material and 7 cc. of a similar solution contain- 
ing 70 rag. of purified Weiss virus material.  The Lee virus material possessed  1270 CCA 
units per rag. of protein, a 50 per cent infectivity end-point in chick embryos at 10  "~'* gin., 
and s sedimentation constant corrected for solution viscosity of 832 S.  The PR8 virus mater- 208  CONCENTRATED  PURIFIED  INI~LUENZA  VIRUS  VACCINES 
ial possessed 2800 CCA units per mg. of protein, a 50 per cent infectivity end-point in chick 
embryos at 10--  ~J gin., and a sedimentation constant corrected for solution viscosity of 719 
S.  The Weiss virus material possessed 1280 CCA units per rag. of protein, a 50 per cent in- 
fectivity end-point in chick embryos at 10--  la.~ gin., and a  sedimentation constant corrected 
for sotution viscosity of about 700 S.  The third of a series of photographs taken at 5 minute 
intervals during sedimentation at 11,100  R.P.~. of the Svensson schlieren diagrams of each 
of the strains at a concentration of 2.5 rag. per ec. is shown as Figs. 7 to 9.  It can be seen 
that the PR8 and Lee boundaries are quite sharp whereas the Weiss boundary is diffuse.  A 
similar photograph for the formalinized mixture of strains at a  concentration of 10 rag. per 
cc. is shown as Fig. 10.  The mixture shows the presence of two components with sedimenta- 
tion constants corrected for solution viscosity of  790 S and 518  S. 
To 26 cc. of the mixture of the three virus materials were added 0.13 cc. of 3.7 per cent 
formaldehyde and 0.13 cc. of a solution containing 2 rag. of phenyl mercuric nitrate per cc. 
The finished vaccine thus contained 5, 2.5, and 2.5 rag. of Lee, PR8, and Weiss virus materials 
per cc., respectively, or a total of 10 rag. of virus materials per cc. in 0.05 ~ sodium phosphate 
at pH 7 in the presence of 1:2000 formalin and 1:100,000 phenyl mercuric nitrate.  After 
standing for 3 days at 4 ° the vaccine was found to be non-infectious for chick embryos when 
tested at 10  "-5, 10  -6, 10-  7, and 10-  s gin. per co., and in tests conducted after an additional 10 
days the vaccine was found to cause no lesions in mice when instilled intranasally at concentra- 
tions of 10--  a, 10  --4, 10  "-~, and 10  -6 gm. per cc.  However, when administered undiluted to five 
mice, equivalent to a concentration of 10  --~ gin. per ec., two of the mice were found to have 
3+ lesions at autopsy and the remainder were negative.  Fourteen days after the preparation 
Of the vaccine, four groups of 66 mice were vaccinated by means of two intraperitoncal doses 
a week apart with a total of 10  "~, 10  -~, 10  -6, and 10-  7 gm. of material, respectively, per mouse. 
In addition, one group of sixteen mice was immunized with the vaccine at a  concentration 
level of 10-  a gin. per cc.  Nine days after the second vaccination dose the mice were divided 
into three groups and tested by means of intranasal instillation of serial tenfold dilutions of 
infectious allantoie fluids containing Lee,  PR8,  and Weiss viruses, respectively.  The Lee 
ailantoic fluid possessed 62 CCA units per cc., a 50 per cent embryo infectivity end-point at 
10-7.Zocc.  , and a weighted 50 per cent mouse end-point at 10  -5.0 cc.  The PR8 ailantoic fluid 
possessed 331 CCA units per cc., a 50 per cent embryo infectivity end-point at 10-  9.1 cc., and 
a weighted 50 per cent mouse end-point at 10  "-~.9 cc.  The Weiss allantoic fluid possessed 92 
CCA units per co., a 50 per cent embryo infectivity end-point at 10  -~-° cc., and a weighted 50 
per cent mouse end-point at 10  ~.o ec. 
It can be seen from the results presented in Table XI  that vaccination with 
the polyvalent vaccine over the range of I0  --4 to 10  -7 gin. provided good protec- 
tion to the mice against several thousand mouse doses of the respective viruses. 
In general, the results are similar to those reported in earlier experiments with 
PR8 virus except that the mice appeared to be somewhat more solidly protected 
against the Weiss virus. 
The administration of 50,000 mouse doses of Weiss virus caused no deaths among mice im- 
munized with 10  "~, 10  -~, or 10  -~ gin. of virus material and two of the five mice vaccinated with 
10-  7 gm. of material survived.  It should be noted that 10  -7 gin. of material is about the 
minimum amount that gives a fair amount of protection to mice for in each case vaccination 
with 10-  s gm. of material gave only a  little protection against 50 to 500 mouse doses.  A 
comparison of the results obtained with the present polyvalent vaccine against PR8 influenza 
virus with those obtained with the polyvaient vaccine prepared by the red cell elution method, 
presented in Table X, indicates that at equivalent dosages there is no great difference in ira- W.  M.  STANLEY  209 
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munizing potency. The fact  that  the vaccine  prepared  by differential  centrifugation  pro- 
tected  fourteen  out  of  fifteen  mice  against  intranasal  dosages  of  up to  about  4,000  50  per  cent 
weighted  mouse doses  following  vaccination  with  only 10  -7  am. of  material,  whereas  the red 
cell  vaccine  at  a  diJution  of  1  :  I000,  corresponding  to  2 X 10  -7  gin.  of  virus  material,  protected 
only  eight  out  of  fifteen  mice  against  intranasal  dosages  of  up to 16,000  mouse doses  could  be 
due to the  fact  that  the  red  cell  vaccine  was used  after  several  months storage. 
As a whole, the results  can be regarded as providing an indication that,  at 
equivalent dosages of virus material, the vaccines prepared by  the red cell 
elution method and by differential  centrifugation are approximately equivalent 
with respect to immunizing potency in mice.  However, since  the vaccine pre- 
pared by the red cell  elution method  contains  only about 0.2 rag. of virus 
material per cc.,  whereas the vaccine prepared by differential  centrifugation 
contains I0 mg. of virus material per cc.,  the latter  is  about 50 times more con- 
centrated than the former.  In immunizing potency, therefore, 1 cc. of  the vac- 
cine prepared by differential  centrifugation would be equivalent to about 50 cc. 
of  the vaccine prepared by the red cell  eintion  method.  The greater concentra- 
tion of  virus materials afforded by the centrifuge product may make it  possible 
to secure better protection in man, especially  if  used in conjunction with adju- 
vants (54),  than would be  possible  with less  concentrated vaccines.  Additional 
advantages may be provided by the fact  that in the case of the centrifuge prod- 
uct the virus materials make up essentially  all of the protein content of the 
vaccine, whereas in the case of the red cell  product the virus materials make up 
only about 20 per cent of  the  protein content of  the vaccine.  The remaining 80 
per cent of the protein content of the vaccine prepared by the red cell  elution 
method consists  of  proteins of low molecular weight which, as indicated by the 
experiments reported above, possess little  or no capacity to induce immunity 
against influenza in mice. 
A vaccine prepared by differential  centrifugation and similar to the one de- 
scribed in this  experiment has been prepared commercially under the auspices 
of the Committee on Medical Research. 
In  tests  in  this  laboratory  the PR8, Lee,  and Weiss  components of  this  vaccine  were found 
to  possess  2900,  2000,  and 1050  CCA units,  respectively,  per  rag.  of  protein. The completed 
vaccine  was found to possess  2050 CCA units  per rag.  of protein. The third  of a series  of 
photographs  taken  at  5  minute  intervals  during  sedimentation  at  11,100  R.P.m.  of  the  Svensson 
schlieren  diagrams of the PR8, Lee,  and Weiss  components and of the completed vaccine 
at  concentrations  of  4.6,  3.5,  4.2,  and 4.0  rag.  per  cc.  is  shown in  Figs.  I! to 14,  respectively. 
In each  instance  there  appears  to be a single  major component although  in the cases  of the 
Weiss component and the completed  vaccine  there  is  evidence  for  the presence  of  some ma- 
terial  of lower  molecular  weight. The sedimentation  constants  not corrected  for solution 
viscosity  were calculated  to be 620 S, 755 S, about 698 S, and 699 S for the PR8, Lee,  and 
Weiss components and for the completed vaccine,  respectively. 
The immunizing potency in mice of the commercially prepared vaccine was 
determined in this  laboratory and the results  are presented in Table Ell.  It W.  M.  STANLEY  211 
can be seen that the immunizing potency is essentially the same as that of the 
vaccine prepared  in  this  laboratory.  The  commercially prepared vaccine is 
now being subjected to clinical tests in man at dosage levels ranging from 0.01 
rag. to 10 rag.  The latter corresponds to a  level approximately 100 times that 
TABLE XII 
Immunizing Potency in Mice of a Commercially Prepared  Vaccine Containing Purified  Lee, 
PRS, and Weiss Virus Materials at Concentrations of Approximately  4.0, 2.2, and 
22 Mg., Respectivdy, per Cc. in 0.05 M Sodium Phospttate at pH 7 and 
Containing 1:2000 Formalin and 1:100,000 Phenyl Mercuric Nilrate 
Vacci- 
nated 
mice 
tested 
with the 
following 
allantoic 
fluids 
Lee* 
PRs~ 
Weiss§ 
rest  I 
50 per ] 
cent  [ 
~o°s".7 
n in- 
oculum 
32,000 
;, 200 
320 
.32 
100,00~ 
0, 00{] 
1,00~ 
10C 
6, 30C 
63{] 
63 
6 
Mice vaccinated twice intraperitoneally a week apart with 0.5 ec. 
portions equivalent to total doses listed below 
Mice not 
vaccinated 
10-4 gln.  10-~  gin.  10  ~  gin.  If)-  7 gin. 
D4,DT,3,  1,  1 
1,  0,  0,  0,  0 
1,  0,  0,  0,  M 
0,  0,"  0,  0,  0 
D2,D=,D=,D2,D2 
Ds,1,  0,  0,  0 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
1,  0,  0,  0,  0 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
0,  0,  0,  0,  0 
D4,Dt,3,  1, 
0,  0,  0,  0, 
0,  0,  0,  0, 
0,  0,  0,  0, 
D2,D~,D~,I, 
2,  0,  0,  0, 
0,  0,  O,  0, 
0,  0,  0,  0, 
1,  0,  0,  0, 
0,  0,  0,  0, 
0,  0,  0,  0, 
0,  0,  0,  0, 
0  Dt,D,,Da,D,,2 
0  2,  1,  1,  0,  0 
0  1,  1,  0,  0,  0 
0  1,  0,  0,  0,  0 
1  D2,D2,D=,D=,Dt 
0  D2,Ds,1,  0,  0 
0  I,  0,  0,  0,  0 
0  1,  0,  0,  0,  0 
0  D~,I,  0,  0,  0 
0  O,  0,  0,  0,  0 
0  .3,  0,  0,  0,  0 
0  0,  0,  0,  0,  0 
Ds,D4,D4,1,  0 
DT,Ds,2,  1,  0 
2,  1,  0,  0,  0 
1,  0,  0,  0,  0 
D=,D=,D~,Ds,2 
D4,Ds,I,  1,  0 
3,  1,  1,  1,  , 
1,  I,  1,  0,  0 
Da,Dt,Dt,I,  0 
Ds,0, 0, 0, 0 
8, I, 0, 0, 0 
I, 0, 0, 0, 0 
D2,D=,D~,D4,0 
D,,D4,Ds, Dg, DI0 
D~,D6,Ds,DT,.3 
Dt,DT,Ds, Dg,4 
D~,D~,Da,Ds,1 
DB,Dt,D4,DT,2 
Ds,Ds,De, 3,  0 
Ds,DI,DIo,4, 2 
D:,D,.D,,  D6,D7 
DT, Ds, Ds. S.  1 
DT,DT,Ds, 4,  2 
D7,3,  2,  2,  2 
* This Lee allantoic fluid was found to possess 98 CCA units per cc. and to have a weighted 
50 per cent end-point in 4-week-old mice at a dilution of 1:104  "~ at the time of administration 
of the test doses. 
$ This PR8 allantoic fluid was found to possess 262  CCA units per cc. and to have a 
weighted 50 per cent end-point in 4-week-old mice at a  dilution of 1:i05"° at the time of 
administration of the test doses. 
§ This Weiss allantoic fluid was found to possess 85  CCA units per cc. and to have a 
weighted 50 per cent end-point in 4-week-old mice at a  dilution of 1:103.8 at the time of 
administration of the test doses. 
of infectious allantoic fluid.  The result~ will be described in later communica- 
tions. 
The Production  of a  Concentrated and Purified Influenza  Virus Vaccine on a 
Large Scale.--A  great many problems intervene when  a  vaccine is manufac- 
tured commercially on a  large scale that do not intervene when the vaccine is 
prepared on a small scale for experimental purposes.  The maintenance, during 
the manufacture of the vaccine, of conditions as nearly bacteriologically sterile 
as possible and the cost of the vaccine are two such problems.  It is relatively 212:  CONCENTRATED  PURIFIED  INFLD~NZA  VIRUS  VACCINES 
easy to harvest the aUantoic fluids of a few hundred embryos and to centrifuge 
a few hundred cubic centimeters of the fluid under absolutely sterile conditions, 
whereas when the operations are carried out on a large scale involving thou- 
sands or hundreds of thousands of embryos, bacterial contamination frequently 
occurs.  Since the purification process involving differential centrifugation  is 
especially suited for the removal of organized bacteria and their soluble com- 
ponents of low molecular weight from the virus material, the contamination of the 
allantoic fluid usually  causes no serious consequences provided  the  bacterial 
contamination is light and the fluid is worked up without delay.  However, it is 
not always possible to obtain such conditions in large scale production; hence, 
it appeared desirable to determine if it would be possible to secure and maintain 
bactericidal or at least bacteriostatic conditions in the fluid containing the virus 
immediately after harvesting and throughout the purification and concentration 
process.  Although inactivation of bacteria and virus by ultraviolet light irra- 
diation immediately after harvesting, followed by the carrying out of all open 
operations under an ultraviolet lamp, was found suitable, such a processing on 
a  large scale would require the installation of considerable irradiation equip- 
ment;  hence,  the present  studies  were directed  towards  the use  of chemical 
inactivating agents. 
In a preliminary experiment with 3600 cc. of PR8 allantoie fluid possessing 235  CCA units 
per cc., one portion was made up to contain 1:1000 formaldehyde and the remainder left un- 
treated.  After standing overnight at 4 ° C. the two portions were processed by differential 
centrifugation.  The formalinized preparation yielded 0.04 rag. of purified material per cc. 
of allantoic fluid and this possessed 1210 CCA units per rag. of protein, whereas the untreated 
portion yielded 0.07 rag. of purified material per cc. of allantoic fluid and this possessed 2460 
CCA units per rag. of protein.  Although the formalinized preparation was sterile and the 
other lightly contamknated the lower yield obtained in the case of the former, both with respect 
to protein and CCA activity, indicated that too much inactivating agent had been used.  In 
another experiment in which 1:2000 formalin was used with PR8 aUantoic fluid containing 
252 CCA units per cc. the yields in the case of the treated and untreated were 0.10 and 0.11 
rag., respectively, per cc. of allantoic fluid.  However, the purified material from the untreated 
sample possessed 2420 CCA units per rag. of protein, whereas that from the formalinized fluid 
possessed  1710  CCA  units per  rag. of  protein.  Hirst  (55)  has noted  that formaldehyde 
has a  slow inactivating effect on CCA activity. 
An experiment was conducted with freshly harvested PR8 aUantoic fluid possessing 245 
CCA units per cc. in which four aliquots of 300 cc. each were used to determine the effect of 
formalin at a  1 : 10,000 dilution, of phenyl mercuric nitrate at a dilution of 1 : 100,000, and of 
phemerol at a 1 : 100,000 dilution.  After standing for 22 hours at 4 ° the untreated sample was 
found to possess 245 CCA units per cc. and to be lightly contaminated with bacteria as indi- 
cated by the presence of 35 colonies on an agar slant after 48 hours' incubation, whereas the 
preparations  containing formalin,  phenyl  mercuric  nitrate,  and  phemerol  possessed  250, 
276, and 250 CCA units per cc., respectively, and gave no bacterial colonies on agar slants on 
48 hours' incubation.  The  four preparations were  subjected to  two  cycles of  differential 
centrifugation and in each case the yield of purified material was 0.10 rag. per cc. of allantoic 
fluid.  The untreated purified preparation was found to possess 3120 CCA units per rag. of W.  M.  STANLEY  213 
protein and a 50 per cent infectivity end-point in chick embryos at 10  -14"4 gin.  The formalin-, 
phenyl mercuric nitrate-, and phemerol treated-purified samples possessed 3350, 3550, and 
3020 CCA units per mg. of protein and 50 per cent chick embryo infectivity end-points at 
10  -n'5' <  10--  ~.6, and <  10  -~.~ gin., respectively. 
The results indicate that  concentrations of 1:10,000 of formalin or of 1:100,- 
000 of either phenyl mercuric nitrate or phemerol are sufficient to achieve and 
maintain  at  least bacteriostatic  and  very  probably  bactericidal  conditions in 
freshly harvested  allantoic  fluids  lightly  contaminated  with  bacteria  without 
affecting the yield or the CCA activity of the virus.  However  in subsequent 
experiments,  in  which  fairly  heavily  contaminated  allantoic  fluids  were  pur- 
posely  employed,  it  was  found  that  occasionally  the  bacteria  continued  to 
increase in number. 
The increase occurred most frequently when phenyl mercuric nitrate was used and least 
frequently when formaldehyde was used.  Since it appeared undesirable to increase the con- 
centration of the bacteriostatic agents, tests were made to determine the effect of combining 
formalin plus phenyl mercuric nitrate at concentrations of 1 : 10,000 and 1 : 100,000, respective- 
ly, in the allantoic fluid followed by the suspension of the sedimented pellets of virus in a 
solution of 0.05 ~  sodium phosphate containing a  part per 2,000 of formalin and a  part per 
100,000  of phenyl mercuric nitrate.  In view of the rather high cost in time  and materials 
of a vaccine containing 10 rag. of virus materials per 1 cc. dose and the fact that a measurable 
degree of protection in man was obtained with a  vaccine containing about 0.2 rag. of virus 
material per  1 cc. dose (39), it appeared that a  vaccine containing an intermediate amount 
of from 1  to 2 mg. of virus material per cc. might suffice  for  vaccination on a  large scale. 
Virus preparations at  this level of concentration are  obtainable readily following a  single 
cycle of differential centrifugation; hence, such preparations were used in the present tests. 
In a  typical experiment 2400 cc. of PR8 aUantoic fluid were harvested by pouring from the 
opened eggs through a  funnel containing a glass wool mat.  The fluid was found to contain 
181 CCA units per cc. and 0.1 cc. applied to a nutrient agar slant gave a confluent growth of 
bacteria after 24 hours' incubation.  Immediately following the harvesting one portion of 
1400 cc. was clarified by centrifugation at 3000 R.P.M. for 10 minutes and the liquid, which then 
contained 160 CCA units per cc., was sedimented at 24,000 R.P.M.  The pellets were suspended 
in 57 cc.  of 0.05 M sodium phosphate buffer at pH  7 and this solution was clarified by 10 
minutes' centrifugatian at 3000  R.P.~.  The clarified solution was found to contain 5360 
CCA units and 2 rag. of protein per cc., hence the yield was 0.08 rag. of virus material per cc. 
of allantoic fluid.  A 0.1 cc. portion of this solution was found to yield a  confluent growth 
of bacteria on an agar slant following 24 hours' incubation.  There was added to the 1000 
cc. portion of allantoic fluid immediately following harvesting, 0.1 cc. of a 37 per'cent solution 
of formaldehyde and 10 cc. of a 0.1 per cent solution of phenyl mercuric nitrate.  The mixture 
was held at 4 ° C. for 24 hours.  At the end of 4 and 24 hours 0.1 cc. portions of the mixture 
gave 80 and 30 bacterial colonies, respectively, on agar slants following 24 hours' incubation. 
The solution was then subjected to a single cycle of differential centrifugation after the manner 
just described for the untreated allantoic fluid, except that the pellets of sedimented virus ma- 
terial were dissolved in 37 cc. of 0.05 ~  sodium phosphate buffer containing a  part per 2000 
of formalin and a  part per 100,000  of phenyl mercuric nitrate.  The final preparation was 
found to contain 75 mg. of virus material possessing 2220 CCA units per rag. of protein; hence 
the yield was 0.075 mg. per cc. of allantoic fluid.  Portions of 0.1 cc. and 1 cc. of the purified 
solution on agar slants and in 10 cc. portions of nutrient broth, respectively, failed to show the 
presence of bacteria following 24 and 48 hours' incubation.  Similar results were obtained 214  CONCENTRATED  PURIFIED INFLUENZA VIRUS VACCINES 
with other samples of PR8 and Lee allantoic fluids.  Sedimentation  diagrams of influenza 
virus preparations  purified and concentrated  by a single cycle of differential centrifugation, 
two of which are shown in Figs. 15 and 16, failed to show the presence of material of low mole- 
cular weight, hence it can be concluded that materials of low molecular weight probably  make 
up less than 5 per cent of such virus preparations.  An idea of the degree of purification that 
can be achieved by differential centrifugation can be obtained from Figs. 17 to 20 which show 
electron micrographs of preparations of normal allantoic fluid, PR8 allantoic fluid, PR8 virus 
purified by a single cycle of differential centrifugation, and PR8 virus purified by two cycles 
of differential centrifugation, respectively.  The characteristic particles having a diameter of 
about 115 m~, are, of course, not present in the normal allantoic fluid but show quite clearly 
in the micrograph of the infectious  allantoic fluid.  The materials of low molecular weight, 
which make up much of the materials shown in  the micrograph of infectious allahtoic fluid, 
are largely absent in the micrograph of the virus preparation  purified and concentrated by a 
single cycle of differential centrifugation. 
The results described indicate  that infectious allantoic fluid, which usually 
has a protein content consisting of less than 10 per cent of virus protein and over 
90 per cent of protein of low molecular weight, can be converted by a  single 
cycle of differential centrifugation to a product in which the virus material com- 
prises the major antigenic component and in which there appears to be less than 
5'per cent of proteins of low molecular weight.  The results also indicate that 
the  bacterial  contamination,  which  invariably  accompanies work on  a  large 
scale, can be controlled by the addition of a part per 10,000 of formalin plus a 
part per 100,000 of phenyl mercuric nitrate  to the aUantoic fluid immediately 
after harvesting followed by the solution of the final product in 0.05  or 0.1  M 
sodium phosphate at pH 7 containing a part per 2000 of formalin plus a part per 
100,000  of phenyl mercuric  nitrate without affecting appreciably the yield or 
CCA activity of the virus.  Influenza virus vaccines have been prepared  by 
the procedure just described by means of the vacuum type air turbine  centri- 
fuge  as  well  as by means  of a  commercially available  Sharpies Laboratory 
Super-Centrifuge and are being subjected to tests for immunizing potency and 
for stability.  Although these vaccines are somewhat less pure  and  less  con- 
centrated  than the vaccines described  earlier  in  this  paper,  which  were pre- 
pared  by  two  cycles  of  differential  centrifugation,  their  compositions  and 
properties are so similar that no marked differences in immunizing potency and 
in stability can be anticipated.  It is probable, therefore, that through the use 
of the Sharpies centrifuge and the procedure just described a  suitable  influenza 
virus vaccine can be prepared on a very large scale with considerable ease and 
efficiency.  1 
* Since the submission of the manuscript  for publication  a  vaccine  has  been  manu- 
factured commercially, by the procedure  described, under the auspices of the Committee 
on Medical Research.  The vaccine was prepared  by means of a single cycle  of differen- 
tial  centrifugation  in  the Sharples  centrifuge  and  contains  1.0, 0.5, and 0.5 rag. of Lee, 
PR8, and Weiss virus materials  per cc. respectively, in 0.1 M sodium phosphate  buffer  at 
pH 7 containing  1:2000 formalin  and  1:100,000 phenyl mercuric  nitrate.  The  average w. M.  STANLEY  215 
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SUMMARY 
Influenza virus vaccines containing from 1 to 10 mg. of virus materials per cc. 
concentrated and purified from infectious allantoic fluids by means of one or 
two cycles of differential centrifugation and inactivated by different treatments 
have been prepared and subjected to laboratory tests.  Suitable inactivation 
of the virus preparations with retention of full red cell agglutinating activity and 
immunizing potency in mice was achieved by treatment with minimal amounts 
of formaldehyde or ultraviolet light.  Treatment with phenol or chloroform 
failed to cause adequate loss of virus activity.  Excessive amounts of formalde- 
hyde or of ultraviolet light were found to cause a loss in red cell agglutinating 
activity and in immunizing potency.  Freezing resulted in the immediate loss 
of red cell agglutinating activity of the formalinized vaccine.  Storage of the 
vaccines in the frozen state was accompanied by a gradual decrease in red cell 
agglutinating activity.  Drying of the vaccines from the frozen state resulted 
in a  loss of red cell agglutinating activity and, in the case of the formalinized 
vaccine, in a loss in immunizing potency.  There appeared to be at least a rough 
correlation between red cell agglutinating activity and immunizing potency. 
The immunizing potency and red cell agglutinating activity of a purified for- 
malinized vaccine containing 2 rag. of virus material per cc. were unchanged 
following 2  months'  storage at  4  °  but were measurably decreased following 
storage for 2 months at 18 to 25 ° and at 37 °.  At equivalent dosages of virus 
material the immunizing potency of formalinized centrifugally purified virus, 
of formalinized virus purified by the red cell elution method, and of infectious 
allantoic fluid was not measurably different.  The immunizing potency of a 
formalinized polyvalent vaccine containing centrifugally purified Lee, PR8, 
and Weiss influenza virus materials at concentrations of 5, 2.5, and 2.5 mg. per 
cc., respectively, was found to be essentially the same as that of a similar vac- 
cine prepared commercially.  In both cases the protection afforded against the 
Weiss strain appeared to be better than that against the Lee and PR8 strains. 
The commercially  prepared vaccine is being subjected to clinical tests in man at 
dosage levels ranging from 0.01  mg.  to  10 rag.  The latter corresponds to a 
level approximately 100 times that of infectious allantoic fluid. 
It was found that the bacterial contamination that frequently accompanies 
operation on a  large scale can be controlled by the addition of one part per 
10,000 of formalin plus one part per 100,000  of phenyl mercuric nitrate to the 
allantoic fluid immediately following harvesting, without affecting the quality 
over-aU yield of virus materials was 0.065 mg. per cc. of a11antoic  fluid, hence one embryo 
yielded about 0.5 rag. of virus  material  The vaccine is  being subjected to laboratory 
and clinical  tests. 216  CONCENTRATED  PURIFIED  INFLUENZA  VIRUS  VACCINES 
of the vaccine.  This procedure and the use of virus materials purified and con- 
centrated  by  a  single  cycle of  differential centrifugation by  means  of  the 
Sharpies centrifuge were found to be suitable for the production of influenza 
virus vaccines on a  large scale.  By means of this method influenza vaccines 
possessing 20 or more times the immunizing potency of infectious allantoic fluid 
and 10 or more times the immunizing potency of the usual commercial vaccine 
prepared by the red cell elution method can be manufactured rapidly on a very 
large scale with considerable ease and efficiency. 
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EXPLANATION  OF  PLATES 
PLATE  6 
The figures show one, usually the fourth, of a series of photographs taken at 5 minute in- 
tervals  during  sedimentation  at  11,100  ~.~.M.  of  the  Svensson  schlieren  diagrams  of 
preparations of influenza virus purified by differential centrifugation and subjected to different. 
treatments.  The sedimentation constant determinations were  kindly made by Dr. M. A 
Lauffer and Mr. H. K. Schachman. 
FIo. 1.  Untreated PR8 virus material at a concentration of 2 rag. per cc. in 0.1 ~r phosphate 
buffer at pH 7.  From  Experiment 1. 
FIo. 2.  Forma|inized PR8 virus material at a concentration of 2 rag. per cc. in 0.1 ~  phos- 
phate buffer at pH 7.  From Experiment 1. 
FIG. 3.  Chloroformized PR8 virus material at a  concentration of 2  rag. per cc. in 0.1 v 
phosphate buffer at pH 7.  From Experiment 1. 
FIG. 4.  Phenolized PR8 virus material at a concentration of 2 rag. per co. in 0.I ~ phosphate 
buffer at pH 7.  From Experiment 1. 
FIG. 5.  Ultraviolet light-treated PR8 virus material at a concentration of 2 mg. per cc. in 
0.1 ~s phosphate buffer at pH 7.  From Experiment 1. 
FIG. 6.  Virus material from vaccine prepared by red cell elution method following further 
purification and concentration by one cycle of differential eentrifugation.  2.1 rag. per co. 
in 0.1 ~  phosphate buffer at pH 7.  From Experiment 6. 
FIo. 7.  Untreated purified Lee virus material used for vaccine described in Experiment 7 
at a concentration of 2.5 rag. per cc. in 0.05 m sodium phosphate buffer at pH 7. 
FIG. 8.  Untreated purified PR8 virus material used for vaccine described in Experiment 7 
at a  concentration of 2.5 rag. per cc. in 0.05 x~ sodium phosphate buffer at pH 7. 
FIG. 9.  Untreated purified Weiss virus material used for vaccine described in Experiment 
7 at a concentration of 2.5 mg. per cc. in 0.05 ~s sodium phosphate buffer at pH 7. 
FIG.  10. Formalinized mixture containing Lee, PR8,  and Weiss virus materials at con- 
¢entrations of 5, 2.5, and 2.5 rag. per ce., respectively, in 0.05 ~  sodium phosphate buffer at 
pH 7.  From Experiment 7. 
FIG. 11.  Untreated commercially prepared PR8 virus material at a  concentration of 4.6 
rag. per cc. in 0.05 ~  sodium phosphate buffer at pH 7. 
FIG.  12.  Untreated commercially prepared Lee virus material at a  concentration of 3.5 
rag. per cc. in 0.05 ~s sodium phosphate buffer at pH 7. 
FIG.  13.  Untreated commercially prepared Weiss virus material at a concentration of 4.2 
mg. per cc. in 0.05 ~  sodium phosphate buffer at pH 7. 
FIG. 14.  Commercially prepared formalinized polyvalent influenza vaccine at a concentra- 
tion of 4 mg. per cc. in 0.05 ~  sodium phosphate buffer at pH 7.  The Lee, PR8, and Weiss 
components are present in the ratio of 2, !, and 1, respectively. 
FIG. 15.  Untreated PR8 influenza virus purified and concentrated by means of one cycle 
of differential centrifugation.  The concentration is 5 rag. per co.  and the solvent is 0.I ~s 
phosphate buffer at pH 7.  The picture is the third of the series and the sedimentation con- 
stant is 657 S. 
FIG.  16. A  preparation of Lee influenza virus purified and concentrated from aUantoic 
fluid containing 1:10,000 formalin plus 1:100,000 phenyl mercuric nitrate by means of one 
cycle of differential centrifugation.  The concentration is 2.6 rag. per cc. and the solvent is 
0.05 ~  sodium phosphate buffer at pH 7 containing 1:2000 formalin and 1:i00,000 phenyl 
mercuric nitrate.  The picture is the third of the series and the sedimentation constant is 
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The figures  show electron micrographs of different preparations taken at 55  kv. with an 
RCA  type  B  instrument  at  a  magnification of 7100 and enlarged to  18,400.  The  virus 
particles are about  115  mu in diameter.  The preparations were applied to  the collodion 
mounts, allowed to dry, then washed with a small volume of distilled water, and allowed to 
dry.  The micrographs were made in the RCA Laboratories in Princeton with the generous 
cooperation of Dr. James Hillier. 
FIG.  17.  Undiluted allantoic fluid from normal embryos. 
FIG. 18.  Undiluted allantoic fluid from embryos infected with PR8 influenza virus.  Arrows 
indicate some of the virus particles. 
FIG.  19.  Virus particles obtained from the infectious allantoic fluid shown in Fig. 18  by 
means of a  single cycle of differential centrifugation.  The  preparation was diluted with 
0.1 M phosphate buffer at pH 7 to give a concentration of 10  4 gin. per cc. and mounted im- 
mediately. 
FIG. 20.  A preparation of PR8 influenza virus concentrated and purified by means of two 
cycles of differential centrifugation.  The preparation was diluted with distilled water to give 
a  concentration of  10  -~ gin. per cc.  and  mounted immediately. THE  JOURNAL OF  EXPERIMENTAL  MEDICINE  VOL.  81  PLATE  7 
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